Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Free Cash Flow (2021 - 2025)

Rxo (RXO) has disclosed Free Cash Flow for 5 consecutive years, with -$9.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 52.63% year-over-year to -$9.0 million, compared with a TTM value of -$8.0 million through Dec 2025, up 85.96%, and an annual FY2025 reading of -$8.0 million, up 85.96% over the prior year.
  • Free Cash Flow was -$9.0 million for Q4 2025 at Rxo, down from $9.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $91.0 million in Q1 2022 and bottomed at -$19.0 million in Q4 2024.
  • Average Free Cash Flow over 5 years is $14.1 million, with a median of $8.0 million recorded in 2023.
  • The sharpest move saw Free Cash Flow plummeted 2000.0% in 2024, then soared 156.25% in 2025.
  • Year by year, Free Cash Flow stood at $27.0 million in 2021, then soared by 114.81% to $58.0 million in 2022, then crashed by 98.28% to $1.0 million in 2023, then tumbled by 2000.0% to -$19.0 million in 2024, then skyrocketed by 52.63% to -$9.0 million in 2025.
  • Business Quant data shows Free Cash Flow for RXO at -$9.0 million in Q4 2025, $9.0 million in Q3 2025, and $9.0 million in Q2 2025.